Treatment for pulmonary fibrosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/505 (2006.01) A61K 31/517 (2006.01)

Patent

CA 2285350

A composition for treating pulmonary fibrosis and a method of using and manufacturing the composition are provided. The composition includes a quinazolinone derivative, preferably Halofuginone. The preferred method of administration is by inhalation, preferably with a pharmaceutically acceptable carrier in the form of an aerosol.

L'invention concerne une composition permettant de traiter la fibrose pulmonaire, ainsi qu'une méthode permettant d'utiliser et de fabriquer ladite composition. Cette dernière contient un dérivé de la quinazolinone, de préférence l'halofuginone. La voie d'administration préférée est l'inhalation, de préférence avec un support pharmaceutiquement acceptable se présentant sous forme d'aérosol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment for pulmonary fibrosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for pulmonary fibrosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for pulmonary fibrosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1682920

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.